Novarsc business down while its modified generic up.

Published: 2006-09-04 07:00:00

Updated: 2006-09-04 07:00:00

The amlodipine drug market has been substantially transformed in which the original product business turned down while the sales of its modified generic version showed ever rising trend. This market also encountered a serious challenge with its isomer products, chiral amlodipine.

The sales of ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK